Meyka Pro banner
Arcellx, Inc.

Arcellx, Inc. (ACLX) Stock Overview

Explore Arcellx, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ACLXNASDAQ
HealthcareBiotechnology
$115.07
$0.02(0.02%)
U.S. Market is Open · 14:17

Arcellx, Inc. (ACLX)

Meyka AI Score

Z

Key Financials

Market Cap6.7B
P/E Ratio-28.27
EPS (TTM)$-4.07
ROE-0.55%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 Months$80.95
1 Year Target$105.92

ACLX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Arcellx, Inc. (NASDAQ: ACLX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Arcellx, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ACLX on the NASDAQ shows an RSI of 0.00, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $105.92 for the NASDAQ listing.

Key metrics behind Arcellx, Inc.'s NASDAQ-traded stock include a P/E ratio of -28.27 and a market capitalization of 6.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ACLX on the NASDAQ.

Price Performance (NASDAQ: ACLX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
0.59%
6-Month Change
60.13%
Year-to-Date (YTD) Change
76.49%
1-Year Change
79.54%
3-Year Change
203.29%
5-Year Change
584.94%
All-Time (Max) Change
584.94%

Contact Information

240 327 0603
25 West Watkins Mill Road, Redwood City, MD, 20878

Company Facts

1,630 Employees
IPO DateFeb 4, 2022
CountryUS

Frequently Asked Questions